Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

IBEX Technologies Inc V.IBT

Healthcare Biotechnology
IBEX Technologies Inc., through its wholly owned subsidiary, IBEX Pharmaceuticals Inc., manufactures and markets enzymes for biomedical use. IBEX Pharmaceutical Inc.’s primary business is the manufacture and selling of high purity enzymes for in-vitro diagnostics and research. The Company also makes and sell osteoarthritis kits (ELISA’s) for pre-clinical research. The Company has developed a proprietary expression for the production of its enzymes in Flavobacterium heparinum. This expression system allows for producing each glycosaminoglycan (GAG) enzyme separately from other enzymes therefore achieving the highest purity using a well-defined proprietary purification scheme. The Company operates in one industry segment: the production and sale of diagnostic products.


TSXV:IBT - Post by User

IBEX Technologies Inc > Looks like IBT Buyback began this AM
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(231)
•••
Post by guarantor1on Aug 11, 2022 10:28am
102 Views
Post# 34888098

Looks like IBT Buyback began this AM

Looks like IBT Buyback began this AMLeede Jones Gable plucks off 10k at .44

Aug 11, 2022 9:39 AM
0.44
-0.005Decrease
-1.124Decrease
10,000
TSXV
Leede Jones Gable Inc.
Anonymous

Assuming it is for the NCIB, because I have not seen Leede Jones buying or selling any Ibex, in the past

"In connection with the NCIB, IBEX has entered into an automatic share purchase plan with Leede Jones Gable Inc. in order to allow for purchases under the NCIB during IBEX’s “black-out” periods, as permitted by the Securities Act (Qubec). Leede Jones Gable Inc. will also effect purchases under the NCIB on behalf of the Company during non-“black-out” periods."
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities